-
The Effect Of Antidiabetic Agent Glibenclamide And Meltformine On Lipids And Glycated Haemoglobin In Type 2 Diabetes Patient Attending Uith Ilorin
REFRENCES -- [Total Page(s) 3]
Page 1 of 3
-
-
-
REFERENCE
Akinmokun, A., Harris, P., Home, P.D. and Alberti, K.G. (1992). Is diabetes always diabetes? Diabetes Research and Clinical Practice. 18:131-136.
Al Homsi, M.F., Lukic, M.L. (2001) An Update on the pathogenesis of Diabetes mellitus, Department of Pathology and Medical Microbiology (Immunology Unit) Faculty of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates. American Diabetes Association. Pp.18-22.
Al-Naama, L., Ajlan, S. and Mahmood, M. (2010). Evalution of lipid and lipoprotein profile in patients with type 2 diabetes. The Medical Journal Basra University. 28(1): 28-32.
Attalah, S. (2007). Markers for side complications amoung diabetic mellitus patients, ph. D. thesis, Department of Natural Science and life, Algeria University. PP. 213.
Barter, P. J. (2011). The causes and consequences of low levels of high density lipoproteins in patients with diabetes. Diabetes & Metabolism Journal. 35(2): 101-106.
Bergman, M., Gidez, L.I. and Eder, H.A. (1990). The effect of glipizide on HDL and HDL subclasses. Diabetes Resource. Pg. 245-248.
Blood, A., Hayes, T.M. and Gamble, D.R. (1975). Register of newly diagnosed diabetic children. BMJ. 3:580-583.
Cagatay, P., Susleyici-Duman, B., Alasya, H. and Ipbuker, A. (2009). Effects of oral antidiabetic drugs over lipid parameters in Turkish type 2 diabetes patients. Acta Medica Academica. 38(2): 77-85.
Campbell, N. (2005). Biology remains unsurpassed. Science. Pp1231
Carlsen, S.M., Rossvoll, O. and Bjerve, K.S., (1996). Metformin improves blood lipid pattern in nondiabetic patients with coronary heart disease. Journal of Internal Medicine. Pg 237-239.
Charles, M.A., Eschwege, E. and Grandmottet, P. (2010). Treatment with metformin of non- diabetic men with hypertension, hypertriglyceridaemia, and central fat distribution: the BIGPRO 1.2 trial. Diabetes Metabolic Resouce Review. Pg. 215.
Dailey, G. E., Mohideen, P. and Fiedorek, F.T. (2002) Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study. Clinical therapeutics. 24(9): 1426- 438.
Dailey, G., Rosenstock, J., Moses, R.G., and Kirk, W. (1995). Insulin Glulisine Provides Improved Glycemic Control in Patients with Type 2 Diabetes. Diabetes Care. Pg. 236.
DeFronzo, R.A. and Goodman, A.M. (1995). Efficacy of metformin in patients with non-insulin-dependent Diabetes mellitus. The Multicenter Metformin Study Group. England Journal Medicine. Pg. 541.
Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.Diabetes prevention program research group. New England Journal Medicine, 346:393–403.
Drouin, P., Standl, E. and Diamicron, M.R. (2004). Gliclazide modified release: results of a 2-year study in patients with type 2 diabetes. Diabetes Obesity Metabolic pg. 414.
Drzewoski, J., Czupryniak, L., Chwatko, G. and Bald, E. (1999). Total plasma homocysteine and insulin levels in type 2 diabetic patients with secondary failure to oral agents. Diabetes Care. Pp. 124.
Fadini I. G. P., Marescotti, E. M.C., de Kreutzenberg, S.V. and Avogaro, A. (2014). Insulin-induced glucose control improves HDL cholesterol levels but not reverse cholesterol transport in type 2 diabetic patients. Atherosclerosis. 235(2): 415-417.
Ginsberg, H., Plutzky, J. and Sobel, B.E. (1999). A review of metabolic and cardiovascular effects of oral antidiabetic agents: beyond glucoselevel lowering. Journal of Cardiovascular Risk. Pg 337
Grant, P.J. (1996). The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes. Diabetes Care pg. 19-21.
Groop, L., Widen, E. and Franssila, A. (1989). Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) Diabetes mellitus. Diabetologia. Pg. 599-605.
Gugliano, D., Ceriello, A. and Paolisso, G. (1996). Oxidative stress and diabetic vascular complications. Diabetes Care. Pg.19.
Guyton, A.C. and Hall, J.E. (2006). Textbook of Medical Physiology. 11th edition, Elsevier Inc. Philadelphia, pp.931-943.
Holt D.B. (2004). The pursuit of heroic masculinity. Journal of Consumer Research. Pp12-14
Ibrahim, A., Alwas, A., Hasan, A., Yousif, E. and Kim B. (2015). Supplement Impact on Cholesterol and Triglycerides, Journal of Pharmaceutical and Medicinal Research. 1(1): 9–10.
REFRENCES -- [Total Page(s) 3]
Page 1 of 3
-
-
ABSRACT - [ Total Page(s): 1 ]Abstract Is Coming Soon ... Continue reading---
APPENDIX A - [ Total Page(s): 1 ]APPENDIX IQUESTIONAIRE TO ACCESS THE ANTHROPOLOGIC INDICES OF PATIENTS WITH TYPE TWO DIABETES MELLITUS ON ANTIDIABETIC DRUGS (METFORMIN AND GLIBENCLAMIDE) ATTENDING UITH ILORIN.INTRODUCTION: I am a final year students of the Department of Medical Laboratory Science, School of Basic Medical Sciences, Kwara State University, Malete, Kwara State. This questionnaire is aimed at accessing the demographic indices of patients with type 2 Diabetes mellitus on metformin and diabinese in Ilorin metropolis ... Continue reading---
APPENDIX B - [ Total Page(s): 5 ]Step 2100µl of the supernatant was dispensed into the clean test tubes respectively.2ml of the cholesterol reagent was addedIt was incubated at room temperature for 10minsAbsorbance of sample against reagent blank was measured at 505nmGlycated HaemoglobinGlycated Haemoglobin is a form of haemoglobin that is measured primarily to identify the three-month average plasma glucose concentration. The test is limited to a three-month average.ProcedureReagentsBlank(µl) samp ... Continue reading---
CHAPTER ONE - [ Total Page(s): 2 ]The present study was designed to investigate and compare the effects of glibenclamide and metformin on prevalence of metabolic syndrome in type 2 diabetic patients.1.2 STATEMENT OF PROBLEMTo know if antidiabetic agents glibenclamide and meltformine has any effect on lipid and glycated haemoglobin in type 2 diabetes patients1.3 AIM OF STUDYTo evaluate the effect of antidiabetic agent glibenclamide and meltformine on lipids and glycated haemoglobin in type 2 diabetes patient attendi ... Continue reading---
CHAPTER TWO - [ Total Page(s): 11 ]Triglycerides as major components of very low-density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice as much energy (approximately 9kcal/g or 38kj/g) as carbohydrates (approximately 4kcal/g or 17kj/g) (Brefere et al., 2014).2.5 Glycated hemoglobin (hemoglobin A1c, HbA1c, A1C, or Hb1c; sometimes also referred to as being Hb1c or HGBA1C) is a form of hemoglobin that is measured primarily to i ... Continue reading---
CHAPTER THREE - [ Total Page(s): 1 ]CHAPTER THREE3.1 Material and Method3.2 Study AreaThe study was carried out at University of Ilorin Teaching Hospital, Ilorin, Kwara State. The hospital is located at the State capital of Ilorin, Kwara State Nigeria. It is a referral center to other public and private hospitals within and outside the state.3.3 SAMPLE SIZE DETERMINATIONThere was a random selection of ninety (90) subjects, 60 were type 2 Diabetes mellitus individual using either one or combine antidiabetic agent (glibe ... Continue reading---
CHAPTER FOUR - [ Total Page(s): 4 ]Tables 4.6: Correlation of Duration in Diabetes and BMI with biochemical parameters (T. cholesterol, High Density Lipoprotein, Low Density Lipoprotein, triglycerides, glycated, and fasting blood sugar) in Diabetic patient using antidiabetic drugs (Metformin and Glianpride). ... Continue reading---
CHAPTER FIVE - [ Total Page(s): 2 ]CHAPTER FIVE5.0 DISCUSSIONThe study shows discrepant results about the influence of metformin on lipid profile (10). Some studies, in agreement with ours, reported reduction only in TC levels (Grant, 1996; Ginsberg et al., 1999), while others reported reduction of TC and TG with an increase of HDL-C (Robinson et al., 1998; Yki-Jarvinen et al., 1999). Still other studies showed no changes in lipid profile (Groop et al., 1998; Rains et al., 1998). Another investigation showed an association of met ... Continue reading---
